SCN2A and Esophageal atresia: Pathogenic variants in SCN2A have been reported in a wide spectrum of neurodevelopmental disorders including developmental and epileptic encephalopathies (EIEE11), benign familial neonatal-infantile seizures (BFIS3), autism spectrum disorder and intellectual disability with and without seizures, and EA.